Health conditions and diseases starting with P. Explore reliable details on symptoms, causes, and treatments to protect your well-being.
Plasmodium vivax is one of the five protozoan species that cause malaria in humans. Unlike the often-deadly Plasmodium falciparum, P. vivax malaria is generally less severe but is notable for its ability to relapse due to dormant liver-stage parasites known as hypnozoites. Its widespread geographic distribution, especially across Asia and Latin America, makes it a
Plasmodium ovale malaria poses a unique challenge due to its capacity for relapse through dormant liver stages known as hypnozoites. While it is not as widespread as P. falciparum or P. vivax, its presence in Sub-Saharan Africa, Southeast Asia, and Papua New Guinea calls for robust prevention measures. We examine effective preventive strategies, including vector
Plasmodium ovale is one of the five species of Plasmodium known to cause malaria in humans. Though less prevalent than P. falciparum or P. vivax, P. ovale is medically significant due to its potential for relapse and its ability to persist in the liver in a dormant form known as the hypnozoite. This article provides
Plasmodium malariae, the causative agent of quartan malaria, continues to persist in various tropical regions despite global malaria reduction efforts. Although typically associated with lower parasitemia and milder symptoms compared to Plasmodium falciparum, its capacity for chronic infection and silent transmission necessitates a targeted approach for prevention. In this article, we outline comprehensive and evidence-based
Plasmodium malariae is one of the five Plasmodium species known to infect humans, responsible for causing quartan malaria. Although less prevalent than P. falciparum and P. vivax, P. malariae presents a persistent threat due to its long-lasting infections, potential to remain undiagnosed for years, and chronic health effects. Comprehensive knowledge of this species is essential
Plasmodium falciparum malaria continues to pose a serious threat to global public health, particularly in sub-Saharan Africa and other tropical regions. Preventing this deadly parasitic disease requires an integrated, multifaceted approach that targets the parasite, its mosquito vector, and the conditions that support its transmission. The following prevention methods reflect current best practices, grounded in
Plasmodium falciparum is the most virulent species of the malaria-causing parasites that infect humans, responsible for the majority of malaria-related deaths worldwide. It thrives in tropical and subtropical regions, with sub-Saharan Africa bearing the highest burden. The disease it causes, falciparum malaria, is a life-threatening condition requiring prompt diagnosis and treatment. Understanding Plasmodium falciparum: The
it is also known as congenital hypoplasminogenemia, is a rare autosomal recessive disorder characterized by a marked reduction in plasminogen activity, which leads to the abnormal accumulation of fibrin-rich pseudomembranes on mucous membranes and other tissues. The disease often manifests early in life and can affect various organs, with serious implications for ocular, respiratory, and
it is a chronic autoimmune skin disorder marked by raised, inflamed, and scaly patches on the skin. As the most common form of psoriasis, it affects approximately 80% to 90% of individuals diagnosed with the condition. Plaque psoriasis results from an overactive immune system that accelerates the life cycle of skin cells, causing them to
it is a highly infectious zoonotic disease caused by the bacterium Yersinia pestis. Historically known for causing devastating pandemics such as the Black Death in the 14th century, plague continues to pose a public health risk in certain parts of the world today. It is transmitted primarily through flea bites, direct contact with infected animals,